Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Mağaza
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Isı Haritası
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
G
GNOM
Global X Genomics & Biotechnology ETF
49.3
2
USD
+0.39%
Sektör:
Finansal
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.39%
Aylık Değişim
+9.48%
6 Aylık Değişim
+6.52%
Yıllık Değişim
+6.52%
Önceki Kapanış
49.1
3
Open
49.3
2
Düşük
49.3
2
High
49.3
2
Hacim
5
Piyasalar
US ETFs
GNOM
Tam grafiği aç
Full chart
Genel Bakış
Tüm yatırımlar
Isı Haritası
En büyük yatırımlar
Market Value
Shares
Weight %
A
AZN
ASTRAZENECA PLC
1.2 M
5 706.0
2.3%
BEAM
Beam Therapeutics Inc
1.2 M
40.6 K
2.2%
TXG
10X Genomics Inc
1.1 M
49.1 K
2.2%
LEGN
Legend Biotech Corp
1.1 M
59.1 K
2.1%
RARE
Ultragenyx Pharmaceutical Inc
930.4 K
39.8 K
1.8%
WGS
GeneDx Holdings Corp
898.3 K
11.3 K
1.7%
WVE
WAVE Life Sciences Ltd
786.3 K
56.4 K
1.5%
Genscript Biotech Corp
761.6 K
498.9 K
1.5%
SRPT
SAREPTA THERAPEUTICS, INC.
686.8 K
41.0 K
1.3%
NTLA
INTELLIA THERAPEUTICS, INC.
621.1 K
45.1 K
1.2%
CDNA
CAREDX, INC.
418.5 K
22.3 K
0.8%
QURE
Uniqure NV
378.9 K
24.2 K
0.7%
VIR
Vir Biotechnology Inc
364.9 K
40.1 K
0.7%
PSNL
Personalis Inc
213.5 K
23.6 K
0.4%
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
200.8 K
119.5 K
0.4%
A
AGILENT TECHNOLOGIES, INC.
200.6 K
1 653.0
0.4%
RCKT
ROCKET PHARMACEUTICALS, INC.
188.2 K
37.6 K
0.4%
PRME
Prime Medicine Inc
187.9 K
40.7 K
0.4%
RGNX
Regenxbio Inc
185.2 K
20.5 K
0.4%
MYGN
MYRIAD GENETICS, INC.
180.9 K
39.2 K
0.3%
1
2
3
Haberler
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
The Next Big Theme: May 2026
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
The Next Big Theme: April 2026
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil